SG11201704780UA - Method for treating heart failure - Google Patents

Method for treating heart failure

Info

Publication number
SG11201704780UA
SG11201704780UA SG11201704780UA SG11201704780UA SG11201704780UA SG 11201704780U A SG11201704780U A SG 11201704780UA SG 11201704780U A SG11201704780U A SG 11201704780UA SG 11201704780U A SG11201704780U A SG 11201704780UA SG 11201704780U A SG11201704780U A SG 11201704780UA
Authority
SG
Singapore
Prior art keywords
heart failure
treating heart
treating
failure
heart
Prior art date
Application number
SG11201704780UA
Inventor
Silviu Itescu
Lee Golden
Original Assignee
Mesoblast Int Sàrl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2014905243A external-priority patent/AU2014905243A0/en
Application filed by Mesoblast Int Sàrl filed Critical Mesoblast Int Sàrl
Publication of SG11201704780UA publication Critical patent/SG11201704780UA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Electrotherapy Devices (AREA)
  • Materials For Medical Uses (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201704780UA 2014-12-23 2015-12-22 Method for treating heart failure SG11201704780UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2014905243A AU2014905243A0 (en) 2014-12-23 Method for treating heart failure
PCT/EP2015/081042 WO2016102597A1 (en) 2014-12-23 2015-12-22 Method for treating heart failure

Publications (1)

Publication Number Publication Date
SG11201704780UA true SG11201704780UA (en) 2017-07-28

Family

ID=55069857

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10202008024VA SG10202008024VA (en) 2014-12-23 2015-12-22 Method for Treating Heart Failure
SG11201704780UA SG11201704780UA (en) 2014-12-23 2015-12-22 Method for treating heart failure

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG10202008024VA SG10202008024VA (en) 2014-12-23 2015-12-22 Method for Treating Heart Failure

Country Status (11)

Country Link
US (2) US11712452B2 (en)
EP (2) EP3236977B1 (en)
JP (3) JP6804451B2 (en)
KR (2) KR20170095932A (en)
CN (2) CN107257687B (en)
AU (2) AU2015371007B2 (en)
BR (1) BR112017012911B1 (en)
CA (1) CA2971512A1 (en)
ES (1) ES2956655T3 (en)
SG (2) SG10202008024VA (en)
WO (1) WO2016102597A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102660506B1 (en) * 2017-05-04 2024-04-25 메조블라스트 인터내셔널 에스에이알엘 Mesenchymal lineage progenitors or stem cells with enhanced immunosuppression
AU2022394471A1 (en) * 2021-11-17 2024-06-20 Mesoblast International Sarl Method of treating progressive heart failure in subjects at high risk of poor outcomes
CN117797243A (en) * 2022-09-30 2024-04-02 上海泽生科技开发股份有限公司 Neuregulin and application thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5030204A (en) 1988-09-28 1991-07-09 Advanced Cardiovascular Systems, Inc. Guiding catheter with controllable distal tip
US5104393A (en) 1989-08-30 1992-04-14 Angelase, Inc. Catheter
US5060660A (en) 1990-02-28 1991-10-29 C. R. Bard, Inc. Steerable extendable guidewire with adjustable tip
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
JPH06509963A (en) 1991-08-28 1994-11-10 メドトロニック　インコーポレーテッド Operable stylet and operation handle assembly
US6251104B1 (en) 1995-05-10 2001-06-26 Eclipse Surgical Technologies, Inc. Guiding catheter system for ablating heart tissue
US6120520A (en) 1997-05-27 2000-09-19 Angiotrax, Inc. Apparatus and methods for stimulating revascularization and/or tissue growth
US6102926A (en) 1996-12-02 2000-08-15 Angiotrax, Inc. Apparatus for percutaneously performing myocardial revascularization having means for sensing tissue parameters and methods of use
AU8401498A (en) * 1997-07-14 1999-02-10 Osiris Therapeutics, Inc. Cardiac muscle regeneration using mesenchymal stem cells
DE19734220C2 (en) 1997-08-07 2000-01-13 Pulsion Verwaltungs Gmbh & Co Catheter system with an insertion wire
US6309370B1 (en) 1998-02-05 2001-10-30 Biosense, Inc. Intracardiac drug delivery
US6432119B1 (en) 1999-03-17 2002-08-13 Angiotrax, Inc. Apparatus and methods for performing percutaneous myocardial revascularization and stimulating angiogenesis using autologous materials
AU2003901668A0 (en) 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
AU2006244639A1 (en) * 2005-03-31 2006-11-16 Mytogen, Inc. Treatment for heart disease
EP2432482B1 (en) * 2009-05-20 2015-04-15 Cardio3 Biosciences S.A. Pharmaceutical composition for the treatment of heart diseases.
NZ608734A (en) * 2010-08-27 2014-09-26 Univ Miami Bone marrow derived cd271 precursor cells for cardiac repair
BR112013004917A2 (en) * 2010-08-31 2016-09-20 Cook General Biotechnology Llc systemic allogeneic stem cell therapies for treating diseases in animals.
CN108635377B (en) * 2011-09-09 2022-06-24 麦瑟布莱斯特公司 Method for increasing osteoblast function
SI2785359T1 (en) * 2011-11-30 2018-11-30 Astellas Institute For Regenerative Medicine Mesenchymal stromal cells and uses related thereto
WO2014057097A1 (en) * 2012-10-12 2014-04-17 INSERM (Institut National de la Santé et de la Recherche Médicale) Modulated mesenchymal stem cells for cardiac cell therapy

Also Published As

Publication number Publication date
CN107257687A (en) 2017-10-17
CN107257687B (en) 2021-12-03
JP7091427B2 (en) 2022-06-27
EP4249056A2 (en) 2023-09-27
CA2971512A1 (en) 2016-06-30
AU2021240102A1 (en) 2021-10-28
ES2956655T3 (en) 2023-12-26
JP7528149B2 (en) 2024-08-05
JP2018500348A (en) 2018-01-11
AU2015371007B2 (en) 2021-07-08
SG10202008024VA (en) 2020-10-29
EP3236977A1 (en) 2017-11-01
KR20240099504A (en) 2024-06-28
AU2015371007A1 (en) 2017-06-29
EP3236977B1 (en) 2023-06-21
WO2016102597A1 (en) 2016-06-30
JP2022113802A (en) 2022-08-04
US11712452B2 (en) 2023-08-01
US20170333482A1 (en) 2017-11-23
CN114224916A (en) 2022-03-25
BR112017012911B1 (en) 2021-10-05
BR112017012911A2 (en) 2018-01-02
JP6804451B2 (en) 2020-12-23
EP4249056A3 (en) 2023-10-18
JP2021035995A (en) 2021-03-04
KR20170095932A (en) 2017-08-23
US20230364149A1 (en) 2023-11-16

Similar Documents

Publication Publication Date Title
ZA201705673B (en) Methods for treating skin
IL279627A (en) Method for the treatment of depression
IL249600A0 (en) Treating myelomas
EP3171786A4 (en) Devices and methods for treating heart failure
GB201406151D0 (en) Method
GB201406155D0 (en) Method
HK1244217A1 (en) Methods for treating proteinopathies
EP3220739A4 (en) Fabric treatment method
GB201410116D0 (en) Method of treatment
GB201403470D0 (en) Method
IL276577A (en) Methods for treating cardiac injury
IL253028A0 (en) Method of treatment
SG10201912688YA (en) A method of treatment
SG11201609522TA (en) Methods for treating cardiovascular diseases
SG11201704780UA (en) Method for treating heart failure
IL254336A0 (en) Novel treatment method
PT3172297T (en) Method for treating algae
SG11201608536QA (en) Method for performing failsafe calculations
AU2014905243A0 (en) Method for treating heart failure
GB201507268D0 (en) Method for stimulating aerogenosis
GB201414611D0 (en) Method for processing tissue
GB201421980D0 (en) Method of treatment
GB201421982D0 (en) Method of treatment
GB201415331D0 (en) Method of treatment
GB201414780D0 (en) Method Of Treatment